Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

IVHIInvech Holdings, Inc.

OTC · CIK 0001009919
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC8742 Services-Management Consulting Services
FY end1231
XBRL facts81

Identity from submissions API

NameInvech Holdings, Inc.
CIK0001009919
TickersIVHI
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC8742 Services-Management Consulting Services
EIN414348617
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone725-200-0178
Website—
Investor website—
Owner org07 Trade & Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Amersin Life Sciences CORP (2005-03-02T05:00:00.000Z → 2006-08-02T04:00:00.000Z)
  • HUBEI PHARMACEUTICAL GROUP LTD (2003-04-10T04:00:00.000Z → 2005-01-31T05:00:00.000Z)
  • PAN ASIA COMMUNICATIONS CORP (2002-09-16T04:00:00.000Z → 2003-03-20T05:00:00.000Z)
  • EXPLORE TECHNOLOGIES INC (1999-07-13T04:00:00.000Z → 2002-06-25T04:00:00.000Z)
Business address
7963 BROADWING DRIVE
LAS VEGAS
NV
89084
NV
Mailing address
7963 BROADWING DRIVE
LAS VEGAS
NV
89084
NV

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

202 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 10-Q/A AMENDMENT NO. 2 0001683168-26-008922 000-25553 261568626 34 3153175 1 1
2026-11-16 NT 10-Q 10-Q EXTENSION FOR SEP 2026 0001683168-26-008823 000-25553 261558935 34 22565
2026-09-15 8-K CURRENT REPORT 5.01,5.02,9.01 0001683168-26-007139 000-25553 261379691 34 322917 1 1
2026-08-21 10-Q/A FORM 10-Q FOR JUNE 2026 0001683168-26-006661 000-25553 261305773 34 2357839 1 1
2026-08-12 10-Q FORM 10-Q FOR JUNE 2026 0001683168-26-006245 000-25553 261265816 34 2309233 1 1
2026-08-04 4 xslF345X06/ownership.xml 0001683168-26-005938 7974
2026-08-04 SC 14F1 FORM SC 14F1 0001683168-26-005933 005-78743 261237275 34 48190
2026-08-03 8-K FORM 8-K 1.01,2.01,5.01,5.02,9.01 0001683168-26-005918 000-25553 261232295 34 301350 1 1
2026-07-10 3 xslF345X06/ownership.xml 0001683168-26-005446 5865
2026-06-04 8-K/A AMENDMENT NO. 1 TO FORM 8-K 1.01,2.01,9.01 0001683168-26-004546 000-25553 261063629 34 203483 1 1
2026-06-04 8-K CURRENT REPORT 1.01,9.01 0001683168-26-004544 000-25553 261063597 34 198628 1 1
2026-05-12 10-Q FORM 10-Q FOR MARCH 2026 0001683168-26-003707 000-25553 26967383 34 2133815 1 1
2026-04-23 8-K CURRENT REPORT 1.01,2.01,3.02,8.01,9.01 0001683168-26-003159 000-25553 26889120 34 242091 1 1
2026-04-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001155 333-294854 26856326 33 2060
2026-04-08 CORRESP filename1.htm 0001683168-26-002744 6566
2026-04-08 UPLOAD filename1.pdf 0000000000-26-003515 333-294854 40363
2026-04-02 S-1 REGISTRATION STATEMENT 0001683168-26-002615 333-294854 26834022 33 2073836 1 1
2026-03-31 8-K FORM 8-K 5.03,8.01,9.01 0001683168-26-002471 000-25553 26818597 34 494064 1 1
2026-03-30 8-K FORM 8-K 1.01,5.03,9.01 0001683168-26-002419 000-25553 26813426 34 368780 1 1
2026-03-05 8-K CURRENT REPORT 1.01,9.01 0001683168-26-001511 000-25553 26724397 34 524668 1 1
2026-03-04 8-K CURRENT REPORT 1.01,2.01,9.01 0001683168-26-001462 000-25553 26719212 34 236853 1 1
2026-02-18 SC 14F1 SCHEDULE 14F-1 0001683168-26-001159 005-78743 26647495 34 49871
2026-02-17 8-K FORM 8-K 1.01,3.02,5.01,5.02,9.01 0001683168-26-001055 000-25553 26636579 34 335694 1 1
2026-01-20 10-K 10-K FOR DEC 2025 0001683168-26-000412 000-25553 26541951 34 2224701 1 1
2025-10-20 10-Q QUARTERLY REPORT 0001683168-25-007656 000-25553 251402914 34 1682275 1 1
2025-09-16 8-K FORM 8-K 8.01 0001683168-25-007032 000-25553 251317269 34 186933 1 1
2025-08-01 10-Q FORM 10-Q FOR JUN 2025 0001683168-25-005573 000-25553 251175181 34 1583967 1 1
2025-05-12 10-Q QUARTERLY REPORT 0001683168-25-003408 000-25553 25933883 34 1531061 1 1
2025-03-11 8-A12G FORM 8-A12G 0001683168-25-001515 000-25553 25728354 34 20078
2025-03-03 10-K FORM 10-K FOR 2024 0001683168-25-001303 000-25553 25696983 34 2676053 1 1
2024-10-31 10-Q FORM 10-Q FOR SEPTEMBER 2024 0001683168-24-007491 000-25553 241413669 34 2071203 1 1
2024-10-30 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-10-30 16:00:00 9999999995-24-003315 333-276779 241412149 33 2031
2024-10-28 CORRESP filename1.htm 0001683168-24-007410 6400
2024-10-04 CORRESP filename1.htm 0001683168-24-006936 14221
2024-10-04 S-1/A AMENDMENT 12 TO FORM S-1 0001683168-24-006934 333-276779 241354590 33 1026873
2024-10-03 UPLOAD filename1.pdf 0000000000-24-011196 333-276779 43440
2024-09-25 S-1/A S-1/A 0001683168-24-006629 333-276779 241321199 33 1026253
2024-09-24 CORRESP filename1.htm 0001683168-24-006630 9249
2024-09-18 8-K FORM 8-K 4.02 0001683168-24-006484 000-25553 241307151 34 195827 1 1
2024-09-11 UPLOAD filename1.pdf 0000000000-24-010268 333-276779 43227
2024-08-29 CORRESP filename1.htm 0001683168-24-006102 10229
2024-08-29 S-1/A S-1/A 0001683168-24-006101 333-276779 241261767 33 911078
2024-08-23 UPLOAD filename1.pdf 0000000000-24-009670 333-276779 43173
2024-08-16 S-1/A AMENDMENT NO 9 0001683168-24-005785 333-276779 241213712 33 886001
2024-08-15 CORRESP filename1.htm 0001683168-24-005787 9715
2024-08-14 UPLOAD filename1.pdf 0000000000-24-009333 333-276779 42527
2024-08-12 10-Q QUARTERLY REPORT 0001683168-24-005462 000-25553 241195334 34 1949522 1 1
2024-08-06 S-1/A FORM S-1 AMENDMENT 8 0001683168-24-005290 333-276779 241178480 33 885586
2024-08-02 CORRESP filename1.htm 0001683168-24-005244 16325
2024-08-02 S-1/A FROM S-1 AMENDMENT 7 0001683168-24-005243 333-276779 241172005 33 884455
2024-08-01 UPLOAD filename1.pdf 0000000000-24-008797 333-276779 43562
2024-07-24 S-1/A FROM S-1 AMENDMENT 6 0001683168-24-005020 333-276779 241136163 33 878187
2024-05-08 8-K FORM 8-K 4.01 0001683168-24-003098 000-25553 24925507 34 196113 1 1
2024-05-03 CORRESP filename1.htm 0001683168-24-002958 6543
2024-05-02 CORRESP filename1.htm 0001683168-24-002915 6256
2024-05-02 CORRESP filename1.htm 0001683168-24-002905 6256
2024-04-22 CORRESP filename1.htm 0001683168-24-002581 9209
2024-04-22 S-1/A FORM S-1 AMENDMENT 5 0001683168-24-002579 333-276779 24861347 33 695250
2024-04-19 UPLOAD filename1.pdf 0000000000-24-004354 333-276779 43591
2024-04-17 CORRESP filename1.htm 0001683168-24-002494 10915
2024-04-17 S-1/A AMENDMENT NO 4 0001683168-24-002493 333-276779 24851297 33 696482
2024-04-17 UPLOAD filename1.pdf 0000000000-24-004180 333-276779 43934
2024-04-09 S-1/A FORM S-1 AMENDMENT 3 0001683168-24-002217 333-276779 24830684 33 696502
2024-04-08 CORRESP filename1.htm 0001683168-24-002218 14632
2024-04-02 UPLOAD filename1.pdf 0000000000-24-003518 333-276779 44510
2024-03-22 CORRESP filename1.htm 0001683168-24-001620 27711
2024-03-22 S-1/A AMENDMENT #2 TO S-1 0001683168-24-001617 333-276779 24773441 33 1095747
2024-03-18 UPLOAD filename1.pdf 0000000000-24-002915 333-276779 48773
2024-03-05 S-1/A AMENDMENT #1 TO FORM S-1 0001683168-24-001299 333-276779 24718025 33 996088
2024-03-04 CORRESP filename1.htm 0001683168-24-001301 66251
2024-02-26 UPLOAD filename1.pdf 0000000000-24-002115 333-276779 59643
2024-01-31 DEL AM DELAYING REQUEST 0001683168-24-000582 333-276779 24583673 33 5583
2024-01-30 S-1 S-1 0001683168-24-000556 333-276779 24582073 33 12116155
2006-08-02 10QSB/A AMERSIN AMENDED Q3-05 A1 0001009919-06-000028 000-25553 06995888 34 5653175
2006-08-02 10QSB/A AMERSIN AMENDED Q2-05 A1 0001009919-06-000026 000-25553 06995880 34 5562978
2006-08-02 10QSB/A AMERSIN 10QSB/A Q1-05 A1 0001009919-06-000024 000-25553 06995852 34 5412387
2006-07-27 10KSB/A AMERSIN AMENDED(1) 10KSB FOR YEAR ENDED 01-31-06 0001009919-06-000022 000-25553 06983447 34 4595849
2006-07-11 UPLOAD filename1.pdf 0000000000-06-032171 34226
2006-07-10 8-K AMERSIN FORM 8-K ITEM 4.02 4.02 0001009919-06-000019 000-25553 06954352 34 16252
2006-06-15 NT 10-Q AMERSIN FORM 12B-25 LATE FILING NOTICE Q1-2006 0001009919-06-000017 000-25553 06907688 34 18286
2006-06-15 15-12G AMERSIN FROM 15-12G 0001009919-06-000014 000-25553 06907569 34 9444
2006-06-14 10KSB AMERSIN 10KSB - JANUARY 31ST, 2006 0001009919-06-000012 000-25553 06903956 34 8574307
2006-06-13 5 PRIMARY DOCUMENT 0001140905-06-000082 4584
2006-06-13 5 PRIMARY DOCUMENT 0001140905-06-000081 6791
2006-06-13 5 PRIMARY DOCUMENT 0001140905-06-000080 4613
2006-06-13 5 PRIMARY DOCUMENT 0001140905-06-000079 4572
2006-05-02 NTN 10Q AMERSIN LATE FILING NOTIFICATION 0001009919-06-000007 000-25553 06797499 34 18343
2006-02-16 5 PRIMARY DOCUMENT 0001009919-06-000005 4486
2006-01-17 10QSB AMERSIN THIRD QUARTER REPORT - OCTOBER 31ST, 2005 0001009919-06-000002 000-25553 06531932 34 6535015
2005-12-27 8-K/A AMENDMENT TO FORM 8-K ITEM 4.02 FILED 14DEC05 4.02 0001009919-05-000046 000-25553 051286909 34 18310
2005-12-27 CORRESP filename1.htm 0001009919-05-000044 8509
2005-12-21 UPLOAD filename1.txt 0000000000-05-063244 5003
2005-12-14 NT 10-Q AMERSIN FORM 12B25 NT-10QSB Q3 0001009919-05-000040 000-25553 051263397 34 18572
2005-12-14 8-K AMERSIN FORM 8-K ITEM 4.02 4.02 0001009919-05-000038 000-25553 051263378 34 17543
2005-11-17 8-K AMERSIN - FORM 8K, APPOINTMENT OF DIRECTOR 5.02 0001009919-05-000036 000-25553 051211953 34 20975
2005-11-16 8-K AMERSIN LIFE SCIENCES 8-K ITEM 5.02 RESIGNATION 5.02 0001009919-05-000034 000-25553 051207762 34 15380
2005-10-20 8-K AMERSIN LIFE SCIENCES CORPORATION FORM 8-K ITEM 2.01 2.01 0001009919-05-000032 000-25553 051147436 34 21916
2005-10-20 10QSB AMERSIN LIFE SCIENCES QUARTERLY REPORT - JULY 31ST, 2005 0001009919-05-000030 000-25553 051146862 34 6330496
2005-09-16 NTN 10Q f050915form12b25.htm 0001009919-05-000021 000-25553 051087539 34 18464
2005-09-16 8-K f050915amls8k.htm 1.02 0001009919-05-000019 000-25553 051087526 34 19237
2005-06-21 10QSB AMERSIN LIFE SCIENCES QUARTERLY REPORT Q1-05 0001009919-05-000015 000-25553 05907115 34 2067802
2005-06-15 NT 10-Q NOTICE OF LATE FILING FOR 1ST QUARTER ENDED 30APR05 0001009919-05-000012 000-25553 05896624 34 17915
2005-06-02 10KSB AMERSIN LIFE SCIENCES CORPORATION ANNUAL REPORT 0001009919-05-000010 000-25553 05872975 34 2067028
2005-05-18 8-K AMERSIN ANNOUNCES DELAY IN FILING ANNUAL REPORT DUE TO AUDITOR???S WORKLOAD 8.01 0001009919-05-000007 000-25553 05841265 34 401768
2005-05-13 5 PRIMARY DOCUMENT 0001140905-05-000063 4541
2005-05-13 5 PRIMARY DOCUMENT 0001140905-05-000062 4581
2005-05-13 5 PRIMARY DOCUMENT 0001140905-05-000061 7456
2005-05-13 5 PRIMARY DOCUMENT 0001140905-05-000060 4554
2005-05-02 NT 10-K doc1.htm 0001140361-05-003332 000-25553 05791684 34 11925
2005-04-21 4 PRIMARY DOCUMENT 0001276310-05-000002 5020
2005-04-06 8-K AMERSIN LIFE SCIENCES 8-K 4-6-2005 8.01 0001015402-05-001743 000-25553 05735865 34 32666
2005-04-05 8-K AMERISIN LIFE SCIENCE CORP. 8-K 3-8-2005 2.02 0001015402-05-001731 000-25553 05734184 34 41269
2005-03-02 8-K HUBEI PHARAMACEUTICALS 8-K 03-01-2005 5.02 0001015402-05-001016 000-25553 05651798 34 8443
2005-01-31 5 PRIMARY DOCUMENT 0001276310-05-000001 12178
2005-01-14 8-K HUBEI PHARMACEUTICAL GROUP 8-K 1-6-2005 5.03,8.01 0001015402-05-000155 000-25553 05529684 34 35265
2005-01-14 10KSB/A HUBEI PHARMACEUTICAL 10KSBA 01-31-2004 0001015402-05-000153 000-25553 05529345 34 44259
2004-12-15 DEF 14C HUBEI PHARMACEUTICAL GROUP, LTD. DEF 14C 12-10-2004 0001015402-04-005425 000-25553 041202970 34 81768
2004-12-13 10QSB HUBEI PHARMACEUTICAL 10QSB 10-31-2004 0001015402-04-005372 000-25553 041197761 34 787510
2004-11-24 8-K HUBEI 8-K 11-18-2004 5.03 0001015402-04-005200 000-25553 041167870 34 24281
2004-11-19 PRE 14C HUBEI PRE 14C 12-10-2004 0001015402-04-005088 000-25553 041156408 34 83334
2004-09-27 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-04-038681 021-69684 04043932 1812
2004-09-23 8-K FORM 8-K FILING DOCUMENT 2.02 0001171843-04-000297 000-25553 041042922 15576
2004-09-22 10QSB HUBEI PHARMACEUTICAL 10QSB 07-31-2004 0001015402-04-003946 000-25553 041040390 872575
2004-09-14 8-K HUBEI PHARMACEUTICAL FORM 8-K FOR EVENTS DATED SEPTEMBER 10, 2004 1.01,9.01 0001015402-04-003854 000-25553 041029049 38468
2004-09-14 NT 10-Q doc1.htm 0001140361-04-005253 000-25553 041028605 10654
2004-09-07 8-K HUBEI PHARMACEUTICAL GROUP LTD. FORM 8-K FOR EVENTS REPORTED JULY 9, 2004 2.01,9.01 0001015402-04-003764 000-25553 041018507 522682
2004-07-22 4 PRIMARY DOCUMENT 0001276310-04-000005 9393
2004-07-12 10KSB/A doc1.txt 0001015402-04-002891 000-25553 04909672 6750
2004-06-22 10QSB doc1.txt 0001015402-04-002658 000-25553 04873386 115043
2004-06-15 NT 10-Q doc1.htm 0001140361-04-003652 000-25553 04862998 10014
2004-05-17 10KSB doc1.txt 0001015402-04-002182 000-25553 04812777 179299
2004-05-17 SC 13D kris13d.htm 0001288425-04-000001 005-78743 04809403 41816
2004-05-17 SC 13D jing13d.htm 0001288426-04-000002 005-78743 04809402 41621
2004-05-17 SC 13D liang13d.htm 0001288427-04-000001 005-78743 04809398 41641
2004-05-12 3 PRIMARY DOCUMENT 0001288426-04-000001 4113
2004-05-03 NT 10-K doc1.htm 0001140361-04-002839 000-25553 04772073 9957
2004-04-20 5 PRIMARY DOCUMENT 0001286998-04-000001 7376
2004-04-07 8-K doc1.txt 5,6 0001015402-04-001385 000-25553 04721474 7631
2004-03-12 8-K doc1.txt 12 0001015402-04-000936 000-25553 04664374 5772
2004-03-09 5/A PRIMARY DOCUMENT 0001276310-04-000003 6337
2004-03-09 5 PRIMARY DOCUMENT 0001276310-04-000002 6260
2004-03-09 3 PRIMARY DOCUMENT 0001276310-04-000001 5555
2003-12-16 10QSB doc1.txt 0001015402-03-004981 000-25553 031056187 112196
2003-12-09 S-8 hubeiesop.htm 0001140905-03-000089 333-111023 031044338 232689
2003-10-28 8-K doc1.txt 1,6 0001015402-03-004213 000-25553 03959878 8567
2003-10-10 8-K/A HUBEI 8-KA 6-27-2003 4 0001015402-03-004047 000-25553 03936774 44705
2003-10-10 8-K/A doc1.txt 4,5 0001015402-03-004041 000-25553 03936189 11161
2003-10-09 10QSB doc1.txt 0001015402-03-004029 000-25553 03934182 137339
2003-10-01 8-K/A doc1.txt 4,5 0001015402-03-003972 000-25553 03919101 11161
2003-09-16 NT 10-Q doc1.htm 0001140361-03-003348 000-25553 03896459 9979
2003-09-04 8-K doc1.txt 2,4,5 0001015402-03-003690 000-25553 03880981 8639
2003-08-29 S-8 hubeis8.htm 0001140905-03-000069 333-108358 03873165 36578
2003-06-25 8-K doc1.txt 5 0001015402-03-002506 000-25553 03755742 10664
2003-06-25 10QSB doc1.txt 0001015402-03-002504 000-25553 03755660 35079
2003-06-13 NT 10-Q doc1.htm 0001140361-03-002021 000-25553 03742975 9975
2003-05-15 10KSB doc1.txt 0001015402-03-001838 000-25553 03700574 81206
2003-04-30 NT 10-K doc1.htm 0001140361-03-001253 000-25553 03674150 9548
2003-04-10 8-K doc1.txt 6,7 0001015402-03-001142 000-25553 03644537 18593
2003-03-20 SC 13D doc1.txt 0001015402-03-000788 005-78743 03610949 13654
2003-03-12 8-K doc1.txt 5,7 0001015402-03-000699 000-25553 03600635 6855
2003-03-10 S-8 doc1.txt 0001015402-03-000679 333-103731 03598991 27346
2003-02-11 SC 13D PAN ASIA SCHEDULE 13D 0001015402-03-000288 005-78743 03549704 14209
2003-02-07 8-K doc1.txt 1 0001015402-03-000267 000-25553 03545381 6899
2003-02-07 SC 13D doc1.txt 0001015402-03-000263 005-78743 03545007 22121
2003-02-04 8-K doc1.txt 1,7 0001015402-03-000219 000-25553 03537814 11647
2002-12-19 10QSB doc1.txt 0001015402-02-004090 000-25553 02863465 21446
2002-12-16 NT 10-Q doc1.htm 0001140361-02-000831 000-25553 02859176 9388
2002-12-10 8-K doc1.txt 1,6 0001015402-02-004048 000-25553 02853350 6510
2002-09-23 10QSB form10qsb.txt 0001062993-02-000479 000-25553 02769690 21817
2002-09-23 8-K form8k.txt 2,7 0001062993-02-000477 000-25553 02769682 9502
2002-09-16 NT 10-Q formnt10q.htm 0001062993-02-000448 000-25553 02764539 9812
2002-06-25 10QSB FORM 10-QSB FOR THE PERIOD ENDED 4/30/2002 0001032210-02-001011 000-25553 02686366 113374
2002-06-18 S-8 POS extls8a.htm 0001096295-02-000003 333-89762 02681241 34110
2002-06-14 S-8 POS extls8a.htm 0001140905-02-000037 333-89762 02678677 34110
2002-06-04 S-8 extls859.htm 0001140905-02-000036 333-89762 02670120 34010
2002-05-28 8-K/A extl8ka.htm 2 0001140905-02-000033 000-25553 02663164 23745
2002-05-28 8-K extl8k2.htm 2 0001140905-02-000032 000-25553 02663147 13497
2002-05-15 8-K extl8k.htm 2 0001140905-02-000022 000-25553 02651308 30010
2002-04-30 10KSB doc1.txt 0001015402-02-001478 000-25553 02627506 46412
2001-12-13 10QSB FORM 10QSB FOR PERIOD ENDED OCTOBER 31, 2001. 0001032210-01-501482 000-25553 1813174 19819
2001-09-14 10QSB FORM 10QSB FOR PERIOD ENDED JULY 31, 2001. 0001032210-01-501089 000-25553 1737424 19648
2001-07-24 DEF 14A DEFINITIVE PROXY STATEMENT 0001032210-01-500869 000-25553 1686696 86814
2001-06-20 PRE 14A PRELIMINARY PROXY STATEMENT 0001032210-01-500704 000-25553 1664047 86251
2001-06-15 10QSB FORM 10QSB FOR PERIOD ENDED APRIL, 30, 2001 0001032210-01-500691 000-25553 1661704 18811
2001-04-30 10KSB FORM 10KSB FOR THE FISCAL YEAR ENDED 01/31/2001 0001032210-01-500434 000-25553 1616254 49082
2000-12-12 10QSB FORM 10-QSB FOR THE PERIOD ENDING 10/31/2000 0001032210-00-002342 000-25553 787776 111079
2000-12-12 8-K FORM 8-K 2,6,7 0001032210-00-002341 000-25553 787770 89908
2000-09-13 10QSB FORM 10QSB FOR THE PERIOD ENDED 07/31/2000 0001032210-00-001863 000-25553 721639 52746
2000-09-11 8-K/A AMENDMENT NO. 1 TO FORM 8-K 2,5,6,7 0001032210-00-001850 000-25553 720681 26037
2000-09-08 8-K FORM 8-K 2,5,6,7 0001032210-00-001843 000-25553 719576 5958
2000-06-19 10QSB 0001.txt 0001062993-00-000078 000-25553 657200 34644
2000-06-19 10-Q 0001.txt 0001062993-00-000077 000-25553 657152 34641
2000-06-14 NT 10-Q 0001.txt 0001062993-00-000074 000-25553 654736 6073
2000-06-08 8-K 0001.txt 2,6,7 0001075793-00-000059 000-25553 651603 92414
2000-05-12 10KSB 0001062993-00-000059 0001062993-00-000059 000-25553 627951 59078
2000-04-28 NTN 10K 0001075793-00-000038 0001075793-00-000038 000-25553 612324 5132
1999-12-14 10QSB 0001062993-99-000053 0001062993-99-000053 000-25553 99774107 27136
1999-09-20 10QSB 0001075793-99-000034 0001075793-99-000034 000-25553 99713705 22844
1999-07-13 10SB12G/A 0001075793-99-000015 0001075793-99-000015 000-25553 99663187 94269
1999-07-13 10QSB 0001075793-99-000014 0001075793-99-000014 000-25553 99663185 22155
1999-05-27 10SB12G/A 0001075793-99-000010 0001075793-99-000010 000-25553 99635879 62885
1999-03-12 10SB12G 0001075793-99-000003 0001075793-99-000003 000-25553 99563954 225375

Latest XBRL company facts

One latest value per concept from companyfacts (81 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 115.89M 2026-11-18 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-01-20 0001683168-26-000412
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 29,099 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 5,391 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 965,964 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap AdjustmentForAmortization Amortization USD 20,984 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 48,603 2026-01-01 2026-03-31 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 20,984 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap Assets Assets USD 559,712 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap AssetsCurrent Assets, Current USD 63,696 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap Cash Cash USD 46 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 46 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 46 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-03-31 2026 Q1 10-Q 2026-05-12 0001683168-26-003707
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 115.89M 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 115.89M 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap CommonStockValue Common Stock, Value, Issued USD 115,894 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap CostOfRevenue Cost of Revenue USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 12,180 2025-01-01 2025-12-31 2025 FY 10-K 2026-01-20 0001683168-26-000412
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 85,376 2024-11-21 2024-11-22 2025 FY 10-K 2026-01-20 0001683168-26-000412
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 90.00M 2024-11-21 2024-11-22 2025 FY 10-K 2026-01-20 0001683168-26-000412
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD 4,443 2025-09-10 2025-09-11 2025 FY 10-K 2026-01-20 0001683168-26-000412
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001683168-25-001303
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 76,680 2025-12-31 2025 FY 10-K 2026-01-20 0001683168-26-000412
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-01-20 0001683168-26-000412
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 76,680 2025-12-31 2025 FY 10-K 2026-01-20 0001683168-26-000412
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 76,680 2025-12-31 2025 FY 10-K 2026-01-20 0001683168-26-000412
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.002 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.002 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001683168-25-001303
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-01-20 0001683168-26-000412
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 66,773 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001683168-26-003707
us-gaap GrossProfit Gross Profit USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -119,313 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001683168-26-003707
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001683168-26-003707
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001683168-26-003707
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 29,099 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 62,150 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 225,000 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 450,000 2026-03-31 2026 Q1 10-Q 2026-05-12 0001683168-26-003707
us-gaap InterestExpense Interest Expense USD 864 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001683168-26-003707
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 145,182 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap Liabilities Liabilities USD 54,944 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 559,712 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap LiabilitiesCurrent Liabilities, Current USD 54,944 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 10,635 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001683168-26-006245
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -10,589 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -212,307 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap NumberOfOperatingSegments Number of Operating Segments Integer 1 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap NumberOfReportableSegments Number of Reportable Segments Integer 1 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap OperatingExpenses Operating Expenses USD 190,459 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -190,459 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 496,016 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -21,848 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001683168-26-006245
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 300,000 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 300,000 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 300 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 63,650 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 48,439 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001683168-25-001303
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 39,600 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001683168-26-003707
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD -37,804 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 52,540 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001683168-26-003707
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -577,390 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap Revenues Revenues USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 504,768 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 92,550 2026-04-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 48,439 2026-04-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 85,376 2024-01-01 2024-12-31 2025 FY 10-K 2026-01-20 0001683168-26-000412
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 517,000 2026-04-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 0 2023-01-01 2023-03-31 2024 Q3 10-Q 2024-10-31 0001683168-24-007491
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 106.79M 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 106.79M 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-18 0001683168-26-008922

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →